Thilo Dörk mostly deals with Genetics, Breast cancer, Genome-wide association study, Internal medicine and Single-nucleotide polymorphism. His research integrates issues of Genetic predisposition and Bioinformatics in his study of Breast cancer. The concepts of his Genome-wide association study study are interwoven with issues in Cancer, Genotyping, Genetic association and Locus.
Thilo Dörk has researched Internal medicine in several fields, including Endocrinology, Oncology and Pathology. His Oncology study combines topics from a wide range of disciplines, such as CHEK2, Case-control study, Penetrance, Prospective cohort study and Risk factor. His Single-nucleotide polymorphism research is mostly focused on the topic SNP.
Thilo Dörk mainly investigates Breast cancer, Internal medicine, Genetics, Oncology and Genome-wide association study. His work in Breast cancer addresses subjects such as Cancer research, which are connected to disciplines such as DNA repair. The various areas that he examines in his Internal medicine study include Missense mutation and Endocrinology.
His Oncology research focuses on Ovarian cancer and how it connects with Serous fluid and Germline. The subject of his Genome-wide association study research is within the realm of Single-nucleotide polymorphism. He has included themes like Genotyping and Candidate gene in his Single-nucleotide polymorphism study.
His main research concerns Breast cancer, Internal medicine, Oncology, Gene and Single-nucleotide polymorphism. His Breast cancer research is multidisciplinary, incorporating perspectives in CHEK2, Cancer research, Allele and Mutation. His Genome-wide association study research extends to Internal medicine, which is thematically connected.
His research in Oncology intersects with topics in Hazard ratio, Ovarian cancer, Prostate cancer and PALB2. His Gene research entails a greater understanding of Genetics. His study on Single-nucleotide polymorphism is covered under Genotype.
His primary areas of study are Breast cancer, Internal medicine, Oncology, Gene and Genome-wide association study. His Breast cancer study incorporates themes from CHEK2, Cancer research, Genetic testing and Risk factor. His Oncology study combines topics in areas such as Odds ratio, Prostate cancer and PALB2.
Gene is a primary field of his research addressed under Genetics. Genome-wide association study is a subfield of Single-nucleotide polymorphism that he tackles. His Single-nucleotide polymorphism research integrates issues from Germline mutation, Epidemiology of cancer, Proportional hazards model and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Emanuele Buratti;Thilo Dörk;Elisabetta Zuccato;Franco Pagani.
The EMBO Journal (2001)
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian.
Nature Genetics (2007)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies
D Easton;L McGuffog;D Thompson;A Dunning.
American Journal of Human Genetics (2004)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: